Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

PMCOL 412 > ALS > Flashcards

ALS Flashcards

1
Q

ALS stands for

A

Amyotrophic Lateral Sclerosis (ALS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ALS aka

A

Lou Gehrig’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ALS definition

A

Rapidly progressive and fatal neurodegenerative disorder of motoneurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ALS affects

A

both corticobulbar (upper) and corticospinal (lower) motoneurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ALS is characterized by

A 
Characterized by scarring in the
lateral tracts of the spinal cord
(hence the name “lateral
sclerosis”), and deposition of
cytoplasmic protein inclusions
(TDP-43, SOD1, FUS etc.)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Death usually occurs within __ of ALS onset

A

5 years; Progression to death for paralysis of respiratory muscles in 3-5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Epidemiology of ALS

A

1.5:100,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Average age of ALS onset

A

52-65 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Symptoms of ALS: 2 main types

A

Progressive muscle weakness and Cognitive changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cognitive changes in ALS

A

may be present in up to 50% of ALS cases

executive dysfunction, language and memory impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Muscle affects in ALS

A

Progressive muscle weakness, fasciculations (muscle twitch) , slowness of movement; respiratory dysfunction in advanced stages with terminal respiratory failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T/F: fasciculations can occur in healthy individuals

A

TRUE

can be due to stress, mineral deficiencies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Other symptoms in ALS

A

Fronto-temporal dementia and psychiatric symptoms develop in 15% of ALS patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ALS and FTD

A

These diseases occur on a continuum known as the ALS-Frontotemporal dementia continuum
With increased motor problems being related to the ALS-heavy end and cognitive/behavioural problems being related to the FTD-hevay end of the spectrum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ALS-Frontotemporal dementia continuum

A

ALS and FTD are considered phenotypic extremes in a spectrum disorder called FTD-motoneuron disease
Can have pure ALS or pure FTD or mixed pathologies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Sporadic ALS accounts for __% of all cases.

A

90%; There is a strong genetic component in sporadic ALS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Familiar ALS account for __% of cases.

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ALS pathogenesis

A

Most likely a combination of both environmental and genetic factors
contribute to the pathogenesis of sporadic ALS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Environmental factors that might (conclusive results are missing) predispose to ALS are:

A
  • lead
  • aluminum
  • exposure to fertilizers and pesticides
  • head injuries/ concussions (increased risk of ALS in war veterans and athletes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Lead vs aluminum in ALS

A

Lead is more studied and found in tissues of ALS–still inconclusive and may only increase risk by 5%
Aluminum–more severe–mice with high aluminum diet develop ALS-like phenotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Most commonly mutated genes in ALS

A

SOD1
TARDBP (TDP-43)
FUS
C9orf72

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

SOD1 gene–what protein

A

Cu-Zn superoxide dismutase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

TARDBP gene–what protein

A

TDP-43

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

ALS genetic: 4 clusters of genes

A

Involved in:

  • cytoskeletal dynamics
  • RNA cycling and life cycle
  • proteostasic mechanisms and autophagy
  • mitochondrial function and oxidative stress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
SOD1 gene is involved in
mitochondrial fucntion and oxidative stress
26
TDP-43 involved in
RNA binding
27
FUS involved in
RNA binding
28
C9orf72 involved in
RNA cycling + life factor
29
In most causes ALS-causing mutations are ____ mutations with the exception of ____
MISSENSE, except C9orf72 which is a massive intro expansion
30
Genes are their penetrance for either FTD or ALS
SOD1 has high penetrance for ALS, but not FTD Tau, GRN, CHMP2B have high penetrance for FTD but not ALS FUS, TDP43 have high penetrance for both C9orf72 has medium penetrance for both
31
ALS molecular mechanisms: overview
- disturbances is protein quality control - microglial hyperactivation - diminished energy supply from a reduction in MCT1 transporter (in oligodendrocyte) - Excitatoicity from reduced glut uptake by astrocytes - mitochondrial dysfunction in motor neurons - disturbances in RNA metabolism - cytoskeletal defects and altered axonal transport
32
Genes involved in cytoskeletal defects and altered axonal transport
Dynactin 1 Profilin 1 Tubulin alpha4A
33
Genes involved in disturbances in RNA metabolism
``` FUS* TDP-43* C9ORF72* hnRNPA1 Matrin 3 ```
34
Genes involved in mitochondrial dysfunction
SOD1* C9ORF72* CHCHD10
35
Genes involved in disturbances in protein quality control
``` Ubiquilin 2 VCP Optineurin Sequestosome 1 TBK1 ```
36
Gene involved in hyperactivative microglia
C9ORF72*
37
___ is the 1st gene associated with familial ALS and __ is most common ALS-causing mutation
SOD1; C9ORF72
38
SOD 1
- the gene coding for superoxide dismutase (SOD) 1 was the first gene associated to familiar ALS - Pathology seems to develop due to a gain of function of the mutant protein, rather than loss of function
39
SOD1 protein role
enzyme responsible for toxification of superoxide anions
40
SOD1 first believed to be _____ BUt is now understood to be due to ____
First believed that ALS from SOD1 was caused by loss of function of enzyme leading to ox stress Now know toxicity is not related to levels of SOD1 activity
41
T/F: Markers of oxidative stress are found in all SOD1 caused ALS states
FALSE; only found in some | SOD1 activity is not related to toxicity
42
SOD1 mutations in ALS result in ____ leading to ....
Abnormal conformations of the protein leading to gain of function including - Formation of protein aggregates (leading to aberrant oxidative chemistry) - “Scavenging” of molecular chaperons - Proteasome inhibition
43
C9ORF72 is unlike other mutations in ALS because
IT is not a missense mutation | It is exanucleotide expansion
44
what is the mutation in C9ORF72 that causes ALS
Expansion of a hexanucleotide GGGGCC repeat in chromosome 9 open reading frame 72 (C9orf72) Healthy individuals have fewer than 23 repeats BUT ALS/FTD patients have hundreds of repeats
45
Proposed mechanism of toxicity of C9orf72: original thought
originally thought to be loss of fucntion leading to less C9orf72 protein causing abnormal microglia response BUT has been shown to have minor role in ALS/FTD pathogenesis
46
Proposed mechanism of toxicity of C9orf72: new understanding
Complex secondary structure arising from repeats leads to gain of function 1) RNA foci leading to sequestration of RNA-binding proteins (disrupted RNA metabolism) 2) DPR proteins translation leading to impaired nucleocytoplasmic transport
47
RAN-translation-mediated toxicity
- Repeat-associated non-ATG (RAN) translation of poly-dipeptide-repeat proteins (DRPs) from expanded exanucleotides in the three possible reading frames (polyGA, polyGP, PolyGR). - RAN translation occurs in the absence of an initiating AUG codon and is initiated by certain RNA secondary structures.
48
RAN Translation occurs in all reading frames, in both directions and results in the production of ___ possible dipeptide repeat (DPR)-proteins
5 - Glycinealanine (GA) - glycine-arginine (GR) - glycine-proline (GP) - proline-arginine (PR) - proline-alanine (PA)
49
The most toxic DPR are
those containing arginine (GR and PR)
50
What mediates the toxicity of DPR
how polar and charged they are because it increases toxic interactions--polyGR, polyPR are highly charged and polar and therefore the most toxic - PolyGA is uncharged and moderately toxic - Poly GP and PA are uncharged, have no intercations and therefore are non-toxic
51
HOW DPRs are toxic--what they cause
- nucleolar dysfunction - impaired nucleocytoplasmic transport - altered RNA granule dynamics - altered intracellular transport - mitochondrial problems (and the induction of oxidative stress) - impaired proteasome function
52
FUS and TDP-43--common roles
Both proteins are ubiquitous and are involved in DNA repair, regulation of RNA transport, translation, splicing, microRNA biogenesis, formation of RNA stress granules.
53
FUS and TDP-43----proposed mechanism of toxicity
- Both proteins redistribute from the nucleus to the cytoplasm if mutated and form aggregates: - Toxicity by gain of function in the cytoplasm - Toxicity by loss of function in the nucleus
54
Mutant TDP-43 effect on mitochondria
Mutant TDP-43 binds to mitochondrial RNA and disrupt the mitochondrial respiratory complex 1
55
RNA granule
aka stress granule contain RNA, act as a RNA reservoir that release RNA for translation when stress is gone (keeps RNAs while translation is halted for when translation begins again)
56
Role of astrocytes in ALS
- Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease - ALS astrocytes induce death of hES cell-derived motoneurons by production of pro-inflammatory cytokines and superoxide (ROS) AKA if you transplant astrocytes from ALS into healthy peeps = get ALS transplant healthy astrocytes into ALS = neuroprotective
57
Microglia in ALS
Decreasing expression of mutant SOD1 specifically in microglia, slows down disease progression ie mutant microglia may have a role in ALS pathology
58
Oligodendrocytes in ALS
Decreased SOD1 expression in oligodendroglia slows down ALS progression more than when SOD1 levels are reduced in neurons i.e. presence of SOD1 in oligodendrocytes is more problematic than SOD1 in neurons
59
Motor neuron death in ALS is due to/largely induced by...
non-cell-autonomous mechanisms involving the dysfunction of glia (esp. astrocytes)
60
T/F there are therapies that block ALS disease progression
FALSE, current therapies only treat symptoms
61
Treatments:
- physical and speech therapy - ADs and benzis - analgesics riluzole and edaravone
62
Physical and speech therapy for ALS
Symptoms control through physical and speech therapy, respiratory exercises.
63
ADs and Benzos
control depression and anxiety associated with ALS
64
Analgesic drugs used for...
for the treatment of musculoskeletal pain, and pain related to cramps and spasticity
65
Only __ FDA approved drugs specific to ALS
TWO | riluzole and edaravone
66
Riluzole
One of only two FDA-approved drug specific for ALS is riluzole, to limit excitotoxic damage and prolong the survival of patients by 3-6 months.
67
edaravone
The second FDA-approved (currently under review by Health Canada) is edaravone, a potent antioxidant with potential neuroprotective effects also in stroke and in PD. Effects are modest in ALS
68
Riluzole action
acts to increase EAAT2 levels to increase the uptake of glutamate by astrocytes prevent excitotoxicity that drives neuronal death in ALS
69
Edaravone action
Blocks ROS that leads to neuronal death in ALS | Mitochondria are disrupted in excitotoxicity and contribute to the damage caused by producing ROS
70
Edaravone clinical trial
saw a 33% decrease in rate of progression
71
ALS tretaments in development--clinical
- Antisense-oligonucleotide (ASO) therapies in clinical trial for SOD1-linked ALS. - ASO for C9ORF72 in clinical trial.
72
ALS treatments in development--preclincal
- Development of RAN-translation inhibitors - Small molecule inhibitors of C9orf72 secondary structures - Immunotherapies targeting TDP-43 or DPR-proteins

PMCOL 412 (35 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions